Blazing Trails with Actionable Genomics
Genomenon CEO Mike Klein elaborates on why it’s such an honor to receive the 2023 Frost & Sullivan Technology Innovation Best Practices Award.
Genomenon and Boston Genetics Join Forces to Curate the Human Genome
Founder Mark Kiel comments on today’s news of the acquisition of leading genomics interpretation and curation company, Boston Genetics, and what it means for the race to curate the human genome.
Mastermind Update: Finding Your Supplemental Match
The Mastermind team has released its latest update to the Genomic Search Engine platform, which aims to help users find their supplemental match and filter by PMID. This update is a significant development for Mastermind, as it takes into account user feedback to provide more personalized and accurate search results.
Mastermind User Group Recap – Salt Lake City, Spring 2023
Last week, the Genomenon team hosted its inaugural User Group Meeting in Salt Lake City. For us, this highly anticipated gathering of Mastermind users was truly special as it marked the beginning of an exciting new tradition of learning and collaboration.
A Rare Breed: Focused on Rare Disease Therapeutics
For Rare Disease Day 2023, we celebrate 10 pharma and biotech companies that are working on cures and novel treatments for rare disease patients.
Why is Estimating Rare Disease Prevalence So Hard?
A recently published paper revealed that the prevalence of ENPP1 deficiency is more than triple the previous estimate. In this blog, co-author and Genomic Science Liaison Lauren Chunn explains why this paper is a must-read for orphan drug developers.